Landec Corporation provided revenue guidance for the full year fiscal 2023. For the year, the company expects Lifecore segment revenue of range of $122 million to $126 million (+12% to +15%).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.69 USD | +5.94% | +10.40% | +8.08% |
Apr. 19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
Apr. 01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.08% | 193M | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Landec Corporation Provides Revenue Guidance for the Full Year Fiscal 2023